Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Combined Phase 2/3 12-week, Randomized, Double-blind, Placebo-controlled Study Investigating the Efficacy of AMT-101 in Subjects With Chronic Antibiotic-resistant Pouchitis

NCT04741087 is registered in ClinicalTrials.gov with Applied Molecular Transport as lead sponsor.

NCT NCT04741087
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04741087 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Combined Phase 2/3 12-week, Randomized, Double-blind, Placebo-controlled Study Investigating the Efficacy of AMT-101 in Subjects With Chronic Antibiotic-resistant Pouchitis
Lead sponsor
Applied Molecular Transport
Phase
Phase 2
Overall status
Completed
Start date
February 5, 2021
Completion date
April 22, 2022
Enrollment
22 (actual)
Sites
34

Conditions

As the registry lists them; a condition with its own page is linked.

pouchitis